{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:46:36Z","timestamp":1773870396348,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,18]]},"DOI":"10.7759\/cureus.105441","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:30:41Z","timestamp":1773844241000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-invasive Evaluation of Myocardial Fibrosis Using T1 and T2 Mapping by Cardiac Magnetic Resonance Imaging"],"prefix":"10.7759","author":[{"given":"Maynor Jose","family":"Lopez Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolle","family":"Contreras Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonieta","family":"Salazar Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeilyn","family":"Jiron Vindas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asdrubal","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jennifer","family":"Valle Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.926378","article-title":"Detection of myocardial fibrosis: where we stand","volume":"9","author":"Zhu L","year":"2022","unstructured":"Zhu L, Wang Y, Zhao S, Lu M. Detection of myocardial fibrosis: where we stand. Front Cardiovasc Med. 2022, 9:926378. 10.3389\/fcvm.2022.926378","journal-title":"Front Cardiovasc Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2024.08.008","article-title":"Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact","volume":"134","author":"Lunde IG","year":"2024","unstructured":"Lunde IG, Rypdal KB, Van Linthout S, Diez J, Gonz\u00e1lez A. Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact. Matrix Biol. 2024, 134:1-22. 10.1016\/j.matbio.2024.08.008","journal-title":"Matrix Biol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2024.02.008","article-title":"Imaging of cardiac fibrosis: how far have we moved from extracellular to cellular?","volume":"54","author":"Telli T","year":"2024","unstructured":"Telli T, Hosseini A, Settelmeier S, et al.. Imaging of cardiac fibrosis: how far have we moved from extracellular to cellular?. Semin Nucl Med. 2024, 54:686-700. 10.1053\/j.semnuclmed.2024.02.008","journal-title":"Semin Nucl Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.06.030","article-title":"Myocardial tissue characterization and fibrosis by imaging","volume":"13","author":"Karamitsos TD","year":"2020","unstructured":"Karamitsos TD, Arvanitaki A, Karvounis H, Neubauer S, Ferreira VM. Myocardial tissue characterization and fibrosis by imaging. JACC Cardiovasc Imaging. 2020, 13:1221-34. 10.1016\/j.jcmg.2019.06.030","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.614235","article-title":"Novel approaches in cardiac imaging for non-invasive assessment of left heart myocardial fibrosis","volume":"8","author":"Mandoli GE","year":"2021","unstructured":"Mandoli GE, D'Ascenzi F, Vinco G, et al.. Novel approaches in cardiac imaging for non-invasive assessment of left heart myocardial fibrosis. Front Cardiovasc Med. 2021, 8:614235. 10.3389\/fcvm.2021.614235","journal-title":"Front Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264867","article-title":"Myocardial fibrosis: emerging target for cardiac molecular imaging and opportunity for image-guided therapy","volume":"64","author":"Bengel FM","year":"2023","unstructured":"Bengel FM, Diekmann J, Hess A, Jerosch-Herold M. Myocardial fibrosis: emerging target for cardiac molecular imaging and opportunity for image-guided therapy. J Nucl Med. 2023, 64:49-58. 10.2967\/jnumed.122.264867","journal-title":"J Nucl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac065","article-title":"Myocardial fibrosis and arrhythmic burden in systemic sclerosis","volume":"61","author":"Ross L","year":"2022","unstructured":"Ross L, Costello B, Brown Z, et al.. Myocardial fibrosis and arrhythmic burden in systemic sclerosis. Rheumatology (Oxford). 2022, 61:4497-502. 10.1093\/rheumatology\/keac065","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-022-00866-0","article-title":"T2 mapping in myocardial disease: a comprehensive review","volume":"24","author":"O'Brien AT","year":"2022","unstructured":"O'Brien AT, Gil KE, Varghese J, Simonetti OP, Zareba KM. T2 mapping in myocardial disease: a comprehensive review. J Cardiovasc Magn Reson. 2022, 24:33. 10.1186\/s12968-022-00866-0","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4641","article-title":"Quantification of myocardial fibrosis using noninvasive T2-mapping magnetic resonance imaging: preclinical models of aging and pressure overload","volume":"35","author":"Lee LE","year":"2022","unstructured":"Lee LE, Chandrasekar B, Yu P, Ma L. Quantification of myocardial fibrosis using noninvasive T2-mapping magnetic resonance imaging: preclinical models of aging and pressure overload. NMR Biomed. 2022, 35:e4641. 10.1002\/nbm.4641","journal-title":"NMR Biomed"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.750626","article-title":"Modulation of cardiac fibrosis in and beyond cells","volume":"8","author":"Fan D","year":"2021","unstructured":"Fan D, Kassiri Z. Modulation of cardiac fibrosis in and beyond cells. Front Mol Biosci. 2021, 8:750626. 10.3389\/fmolb.2021.750626","journal-title":"Front Mol Biosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-23-01068","article-title":"Cardiac fibrosis as a predictor for sudden cardiac death after transcatheter aortic valve implantation","volume":"20","author":"Alnour F","year":"2024","unstructured":"Alnour F, Beuthner BE, Hakroush S, et al.. Cardiac fibrosis as a predictor for sudden cardiac death after transcatheter aortic valve implantation. EuroIntervention. 2024, 20:e760-9. 10.4244\/EIJ-D-23-01068","journal-title":"EuroIntervention"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1070973","article-title":"Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention","volume":"14","author":"Yin X","year":"2023","unstructured":"Yin X, Yin X, Pan X, et al.. Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention. Front Pharmacol. 2023, 14:1070973. 10.3389\/fphar.2023.1070973","journal-title":"Front Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092412","article-title":"Mechanisms of fibroblast activation and myocardial fibrosis: lessons learned from FB-specific conditional mouse models","volume":"10","author":"Umbarkar P","year":"2021","unstructured":"Umbarkar P, Ejantkar S, Tousif S, Lal H. Mechanisms of fibroblast activation and myocardial fibrosis: lessons learned from FB-specific conditional mouse models. Cells. 2021, 10:2412. 10.3390\/cells10092412","journal-title":"Cells"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27248784","article-title":"Proteomic insights into cardiac fibrosis: from pathophysiological mechanisms to therapeutic opportunities","volume":"27","author":"Qi R","year":"2022","unstructured":"Qi R, Lin E, Song J, Wang Y, Lin L. Proteomic insights into cardiac fibrosis: from pathophysiological mechanisms to therapeutic opportunities. Molecules. 2022, 27:8784. 10.3390\/molecules27248784","journal-title":"Molecules"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914845","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: a perspective from fibroblasts","volume":"24","author":"Schlittler M","year":"2023","unstructured":"Schlittler M, Pramstaller PP, Rossini A, De Bortoli M. Myocardial fibrosis in hypertrophic cardiomyopathy: a perspective from fibroblasts. Int J Mol Sci. 2023, 24:4845. 10.3390\/ijms241914845","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.529075","article-title":"The dynamic interplay between cardiac inflammation and fibrosis","volume":"11","author":"Thomas TP","year":"2020","unstructured":"Thomas TP, Grisanti LA. The dynamic interplay between cardiac inflammation and fibrosis. Front Physiol. 2020, 11:529075. 10.3389\/fphys.2020.529075","journal-title":"Front Physiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092178","article-title":"Novel therapies for the treatment of cardiac fibrosis following myocardial infarction","volume":"10","author":"Raziyeva K","year":"2022","unstructured":"Raziyeva K, Kim Y, Zharkinbekov Z, Temirkhanova K, Saparov A. Novel therapies for the treatment of cardiac fibrosis following myocardial infarction. Biomedicines. 2022, 10:2178. 10.3390\/biomedicines10092178","journal-title":"Biomedicines"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.044","article-title":"Myocardial edema measured by T2 mapping is an independent predictor of ventricular arrhythmias in hypertrophic cardiomyopathy","volume":"44","author":"Kirshenboim Z","year":"2023","unstructured":"Kirshenboim Z, Fardman A, Shagraui R, et al.. Myocardial edema measured by T2 mapping is an independent predictor of ventricular arrhythmias in hypertrophic cardiomyopathy. Eur Heart J. 2023, 44:ehad655. 10.1093\/eurheartj\/ehad655.044","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021201630","article-title":"High-spatial-resolution 3D whole-heart MRI T2 mapping for assessment of myocarditis","volume":"298","author":"Bustin A","year":"2021","unstructured":"Bustin A, Hua A, Milotta G, et al.. High-spatial-resolution 3D whole-heart MRI T2 mapping for assessment of myocarditis. Radiology. 2021, 298:578-86. 10.1148\/radiol.2021201630","journal-title":"Radiology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-023-00951-y","article-title":"Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy","volume":"25","author":"Sunthankar SD","year":"2023","unstructured":"Sunthankar SD, George-Durrett K, Crum K, et al.. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy. J Cardiovasc Magn Reson. 2023, 25:44. 10.1186\/s12968-023-00951-y","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.268","article-title":"T2 mapping as a marker of active myocardial injury in Anderson-Fabry disease patients","volume":"45","author":"Schiavo M","year":"2024","unstructured":"Schiavo M, Torlasco C, Ditaranto R, et al.. T2 mapping as a marker of active myocardial injury in Anderson-Fabry disease patients. Eur Heart J. 2024, 45:ehae666. 10.1093\/eurheartj\/ehae666.268","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.122.014743","article-title":"Cardiovascular magnetic resonance tissue characterization by T1 and T2 mapping: a moving target in need of stable references","volume":"15","author":"Jerosch-Herold M","year":"2022","unstructured":"Jerosch-Herold M, Petersen SE. Cardiovascular magnetic resonance tissue characterization by T1 and T2 mapping: a moving target in need of stable references. Circ Cardiovasc Imaging. 2022, 15:e014743. 10.1161\/CIRCIMAGING.122.014743","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132440","article-title":"Magnetic resonance mapping for the assessment of cardiomyopathies and myocardial disease","volume":"415","author":"Gravina M","year":"2024","unstructured":"Gravina M, Casavecchia G, Mangini F, et al.. Magnetic resonance mapping for the assessment of cardiomyopathies and myocardial disease. Int J Cardiol. 2024, 415:132440. 10.1016\/j.ijcard.2024.132440","journal-title":"Int J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27459","article-title":"Reference ranges, diagnostic and prognostic utility of native T1 mapping and extracellular volume for cardiac amyloidosis: a meta-analysis","volume":"53","author":"Wang TK","year":"2021","unstructured":"Wang TK, Brizneda MV, Kwon DH, et al.. Reference ranges, diagnostic and prognostic utility of native T1 mapping and extracellular volume for cardiac amyloidosis: a meta-analysis. J Magn Reson Imaging. 2021, 53:1458-68. 10.1002\/jmri.27459","journal-title":"J Magn Reson Imaging"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020317","article-title":"Imaging challenges in patients with severe aortic stenosis and heart failure: did we find a way out of the labyrinth?","volume":"11","author":"Gonska B","year":"2022","unstructured":"Gonska B, Buckert D, M\u00f6rike J, et al.. Imaging challenges in patients with severe aortic stenosis and heart failure: did we find a way out of the labyrinth?. J Clin Med. 2022, 11:20317. 10.3390\/jcm11020317","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-020-00632-0","article-title":"Real-time cardiovascular magnetic resonance T1 and extracellular volume fraction mapping for tissue characterisation in aortic stenosis","volume":"22","author":"Backhaus SJ","year":"2020","unstructured":"Backhaus SJ, Lange T, Beuthner BE, et al.. Real-time cardiovascular magnetic resonance T1 and extracellular volume fraction mapping for tissue characterisation in aortic stenosis. J Cardiovasc Magn Reson. 2020, 22:46. 10.1186\/s12968-020-00632-0","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2021.07.023","article-title":"T1 mapping and extracellular volume fraction in dilated cardiomyopathy: a prognosis study","volume":"15","author":"Li S","year":"2022","unstructured":"Li S, Zhou D, Sirajuddin A, et al.. T1 mapping and extracellular volume fraction in dilated cardiomyopathy: a prognosis study. JACC Cardiovasc Imaging. 2022, 15:578-90. 10.1016\/j.jcmg.2021.07.023","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.236","article-title":"The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy","volume":"45","author":"Wang J","year":"2024","unstructured":"Wang J, Zhang J, Wan K, et al.. The prognostic and incremental value of T1 mapping for predicting adverse events in hypertrophic cardiomyopathy. Eur Heart J. 2024, 45:ehae666.236. 10.1093\/eurheartj\/ehae666.236","journal-title":"Eur Heart J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-023-00919-y","article-title":"Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy","volume":"25","author":"Cadour F","year":"2023","unstructured":"Cadour F, Quemeneur M, Biere L, et al.. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy. J Cardiovasc Magn Reson. 2023, 25:7. 10.1186\/s12968-023-00919-y","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac098","article-title":"Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation","volume":"61","author":"De Luca G","year":"2022","unstructured":"De Luca G, Palmisano A, Campochiaro C, et al.. Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation. Rheumatology (Oxford). 2022, 61:4409-19. 10.1093\/rheumatology\/keac098","journal-title":"Rheumatology (Oxford)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-023-00973-6","article-title":"Free-breathing simultaneous native myocardial T1, T2 and T1\u03c1 mapping with Cartesian acquisition and dictionary matching","volume":"25","author":"Lyu Z","year":"2023","unstructured":"Lyu Z, Hua S, Xu J, Shen Y, Guo R, Hu P, Qi H. Free-breathing simultaneous native myocardial T1, T2 and T1\u03c1 mapping with Cartesian acquisition and dictionary matching. J Cardiovasc Magn Reson. 2023, 25:63. 10.1186\/s12968-023-00973-6","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.230145","article-title":"Histopathologic validation of stress T1 mapping in myocardial ischemia: another step toward clinical translation?","volume":"5","author":"Burrage MK","year":"2023","unstructured":"Burrage MK, Ferreira VM. Histopathologic validation of stress T1 mapping in myocardial ischemia: another step toward clinical translation?. Radiol Cardiothorac Imaging. 2023, 5:e230145. 10.1148\/ryct.230145","journal-title":"Radiol Cardiothorac Imaging"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10100-9","article-title":"Contrast-enhanced cardiac MRI is superior to non-contrast mapping to predict left ventricular remodeling at 6 months after acute myocardial infarction","volume":"34","author":"Chen H","year":"2024","unstructured":"Chen H, Erley J, Muellerleile K, et al.. Contrast-enhanced cardiac MRI is superior to non-contrast mapping to predict left ventricular remodeling at 6 months after acute myocardial infarction. Eur Radiol. 2024, 34:1863-74. 10.1007\/s00330-023-10100-9","journal-title":"Eur Radiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1649728","article-title":"Imaging myocardial scar in hypertrophic cardiomyopathy: advances in CMR and CT","volume":"12","author":"Sclafani M","year":"2025","unstructured":"Sclafani M, Perrotti C, Salerno L, et al.. Imaging myocardial scar in hypertrophic cardiomyopathy: advances in CMR and CT. Front Cardiovasc Med. 2025, 12:1649728. 10.3389\/fcvm.2025.1649728","journal-title":"Front Cardiovasc Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-020-00627-x","article-title":"Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis","volume":"22","author":"Snel GJ","year":"2020","unstructured":"Snel GJ, van den Boomen M, Hernandez LM, et al.. Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis. J Cardiovasc Magn Reson. 2020, 22:34. 10.1186\/s12968-020-00627-x","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020337","article-title":"CMR mapping: the 4th-era revolution in cardiac imaging","volume":"13","author":"Carrabba N","year":"2024","unstructured":"Carrabba N, Amico MA, Guaricci AI, et al.. CMR mapping: the 4th-era revolution in cardiac imaging. J Clin Med. 2024, 13:337. 10.3390\/jcm13020337","journal-title":"J Clin Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220067","article-title":"Clinical impact of cardiac MRI T1 and T2 parametric mapping in patients with suspected cardiomyopathy","volume":"305","author":"Warnica W","year":"2022","unstructured":"Warnica W, Al-Arnawoot A, Stanimirovic A, et al.. Clinical impact of cardiac MRI T1 and T2 parametric mapping in patients with suspected cardiomyopathy. Radiology. 2022, 305:319-26. 10.1148\/radiol.220067","journal-title":"Radiology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.5043","article-title":"Synthetic multi-contrast late gadolinium enhancement imaging using post-contrast magnetic resonance fingerprinting","volume":"37","author":"Rashid I","year":"2024","unstructured":"Rashid I, Al-Kindi S, Rajagopalan V, Walker J, Rajagopalan S, Seiberlich N, Hamilton JI. Synthetic multi-contrast late gadolinium enhancement imaging using post-contrast magnetic resonance fingerprinting. NMR Biomed. 2024, 37:e5043. 10.1002\/nbm.5043","journal-title":"NMR Biomed"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030743","article-title":"Clinical utility of strain imaging in assessment of myocardial fibrosis","volume":"12","author":"Gao L","year":"2023","unstructured":"Gao L, Zhang L, Zhang Z, et al.. Clinical utility of strain imaging in assessment of myocardial fibrosis. J Clin Med. 2023, 12:743. 10.3390\/jcm12030743","journal-title":"J Clin Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2021.01.027","article-title":"Multimodality imaging assessment of myocardial fibrosis","volume":"14","author":"Gupta S","year":"2021","unstructured":"Gupta S, Ge Y, Singh A, Gr\u00e4ni C, Kwong RY. Multimodality imaging assessment of myocardial fibrosis. JACC Cardiovasc Imaging. 2021, 14:2457-69. 10.1016\/j.jcmg.2021.01.027","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-316646","article-title":"Will electrocardiographic detection of myocardial fibrosis work?","volume":"106","author":"Aro AL","year":"2020","unstructured":"Aro AL. Will electrocardiographic detection of myocardial fibrosis work?. Heart. 2020, 106:958-9. 10.1136\/heartjnl-2020-316646","journal-title":"Heart"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473892-non-invasive-evaluation-of-myocardial-fibrosis-using-t1-and-t2-mapping-by-cardiac-magnetic-resonance-imaging","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:30:41Z","timestamp":1773844241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473892-non-invasive-evaluation-of-myocardial-fibrosis-using-t1-and-t2-mapping-by-cardiac-magnetic-resonance-imaging"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.105441","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}